Outlook Therapeutics, Inc. (OTLK) Earnings
|
Expand Research on OTLK
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/25  |
Q325 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/25 | Q325 | -$0.44 | $0.00 | -$0.44 | $1.51M | N/A | N/A |  | | Details | |
| 5/15/24 | Q224 | N/A | -$0.98 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/13/24 | Q124 | N/A | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 12/21/23 | Q423 | N/A | -$0.06 | N/A | N/A | $2.43M | N/A | N/A | N/A | ||
| 8/17/23 | Q323 | N/A | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/18/23 | Q223 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/15/23 | Q123 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A |
